Insider Trades of ARCH VENTURE FUND VII LP Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company ▼ Relation Last Date Type Tran OwnerType Shares Traded Last Price Shares Held
SAGE THERAPEUTICS, INC. Beneficial Owner (10%) 07/23/2014 Form 4 Acquisition (Non Open Market) direct 4,249,389 0 4,249,389
SAGE THERAPEUTICS, INC. Beneficial Owner (10%) 01/14/2015 Form 4 Disposition (Non Open Market) direct 1,062,345 0 3,187,044
SAGE THERAPEUTICS, INC. Beneficial Owner (10%) 06/18/2015 Form 4 Disposition (Non Open Market) direct 1,062,345 0 2,124,699
JUNO THERAPEUTICS, INC. Beneficial Owner (10%) 12/23/2014 Form 4 Acquisition (Non Open Market) direct 10,455,375 0 11,552,390
JUNO THERAPEUTICS, INC. Beneficial Owner (10%) 03/15/2016 Form 4 Disposition (Non Open Market) direct 1,000,000 0 10,552,390
AGIOS PHARMACEUTICALS INC Beneficial Owner (10%) 02/19/2015 Form 4 Disposition (Non Open Market) direct 386,074 0 3,088,590

Create your free portfolio